Schrezenmeier, Hubert
Schrezenmeier, H. (Hubert)
Schrezenmeier, H.
Hubert Schrezenmeier researcher (ORCID 0000-0003-1222-6659)
VIAF ID: 28771439 (Personal)
Permalink: http://viaf.org/viaf/28771439
Preferred Forms
-
100 0 _
‡a
Hubert Schrezenmeier
‡c
researcher (ORCID 0000-0003-1222-6659)
-
200 _ |
‡a
Schrezenmeier
‡b
Hubert
-
100 1 _
‡a
Schrezenmeier, H.
-
100 1 0
‡a
Schrezenmeier, H.
‡q
(Hubert)
-
100 1 _ ‡a Schrezenmeier, H. ‡q (Hubert)
-
100 1 _ ‡a Schrezenmeier, Hubert
-
100 1 _
‡a
Schrezenmeier, Hubert
-
100 1 _
‡a
Schrezenmeier, Hubert
-
100 1 _ ‡a Schrezenmeier, Hubert (sparse)
4xx's: Alternate Name Forms (3)
Works
| Title | Sources |
|---|---|
| 53. Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie (DGTI), 16.-18. Sepember 2020, Digital abstracts |
|
| Aplastic anemia, 1993: |
|
| Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry |
|
| Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects |
|
| Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19 |
|
| Effects of circulating HMGB-1 and histones on cardiomyocytes−hemadsorption of these DAMPs as therapeutic strategy after multiple trauma |
|
| Eisenmangelanämie 12 Tabellen |
|
| Hämolytische und aplastische Anämien als Erkrankungen aus dem Formenkreis der klassischen Hämatologie |
|
| Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness : A German Multicenter Analysis |
|
| Natural killer cells generated from human induced pluripotent stem cells mature to CD56brightCD16+NKp80+/-in-vitro and express KIR2DL2/DL3 and KIR3DL1 |
|
| Osteoarthritic Milieu Affects Adipose-Derived Mesenchymal Stromal Cells |
|
| Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease |
|
| Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change |
|
| Strukturvarianten von Peptidhormonen Untersuchungen am Beispiel neuer ACTH-Homologa aus Schweinehypophysen |
|
| Superior physical and mental health of healthy volunteers before and five years after mobilized stem cell donation |
|
| Untersuchungen zur Pathophysiologie der Aplastischen Anämie und der Paroxysmalen nächtlichen Hämoglobinurie |
|
